High Court Interprets The Biosimilars Statute — What Now?
On Monday, the U.S. Supreme Court issued its first interpretation of the biosimilars statute, the Biologics Price Competition and Innovation Act of 2009. The BPCIA, part of Obamacare, introduced an abbreviated...To view the full article, register now.
Already a subscriber? Click here to view full article